BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological activity of 5-aza-ellipticine derivatives. 2007

Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Structural Biophysics Laboratory, Molecular Aspects of Drug Design Section, Structural Biophysics Laboratory, NCI-Frederick, PO Box B Frederick, MD 21702, USA.

Novel 5-aza-ellipticine derivatives were synthesized and tested as antitumor agents. The new compounds were prepared more readily than the analogous ellipticine derivatives, which are known to be potent anti-tumor agents Although the novel 5-aza-ellipticine derivatives are not as biologically active as their corresponding ellipticine analogues, the new compounds represent a new, readily accessible class of heteroaromatic catalytic inhibitors of topoisomerase II and possible anti-tumor agents.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004611 Ellipticines Pyrido-CARBAZOLES originally discovered in the bark of OCHROSIA ELLIPTICA. They inhibit DNA and RNA synthesis and have immunosuppressive properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001372 Aza Compounds Organic chemicals where carbon atoms have been replaced by nitrogen atoms. Compounds, Aza
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D059005 Topoisomerase II Inhibitors Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. DNA Gyrase Inhibitor,DNA Topoisomerase II Inhibitor,Topoisomerase 2 Inhibitors,Topoisomerase II Inhibitor,DNA Gyrase Inhibitors,DNA Topoisomerase II Inhibitors,DNA Type 2 Topoisomerase Inhibitors,Gyrase Inhibitor, DNA,Gyrase Inhibitors, DNA,II Inhibitor, Topoisomerase,Inhibitor, DNA Gyrase,Inhibitor, Topoisomerase II,Inhibitors, DNA Gyrase,Inhibitors, Topoisomerase 2,Inhibitors, Topoisomerase II
D020128 Inhibitory Concentration 50 The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture. IC50,Concentration 50, Inhibitory

Related Publications

Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis and biological activity of 5'-aminobenzoxazinorifamycin derivatives.
October 1992, Chemical & pharmaceutical bulletin,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis and biological activity of 5-(4-methoxyphenyl)-oxazole derivatives.
January 2015, Bioorganic & medicinal chemistry letters,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.
January 1993, Chemical & pharmaceutical bulletin,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis and anti-trypanosomal activity of various 8-aza-7-deaza-5'noraristeromycin derivatives.
February 1997, Journal of medicinal chemistry,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
[Myelopeptide MP-5 and fluorescent derivatives: synthesis and biological activity].
January 2008, Bioorganicheskaia khimiia,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis, reactivity, and biological activity of 5-aminouracil and its derivatives.
February 2016, Molecular diversity,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis, biological evaluation, and structure-activity relationship study of novel cytotoxic aza-caffeic acid derivatives.
September 2010, Bioorganic & medicinal chemistry,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis and anticancer activity of novel aza-artemisinin derivatives.
July 2017, Bioorganic & medicinal chemistry,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
Synthesis and anticancer activity of 4-aza-daurinol derivatives.
November 2015, Archives of pharmacal research,
Deborah L Moody, and Marcin Dyba, and Teresa Kosakowska-Cholody, and Nadya I Tarasova, and Christopher J Michejda
DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
March 2009, ChemMedChem,
Copied contents to your clipboard!